« Day Off | Main | Massacree HD »
April 19, 2004
CoQ10 On The Fast Track
In a sparsely worded press release Tishcon Corporation announced that they have received orphan drug status for CoQ10. This speeds up the time when CoQ10 might be an approved drug for Huntington's Disease. For those with insurance that could save them $100+/mo in costs over what is paid today.
Here's the press release:
Tishcon Corp. Receives Orphan Drug Designations for Coenzyme Q10 in the Treatment of Pediatric Congestive Heart Failure and Huntington's Disease
WESTBURY, N.Y., April 19 /PRNewswire/ -- Tishcon Corp. announced that the
U.S. FDA has granted the firm Orphan Drug Designations for UBIQUINOL (Coenzyme
Q10) in the treatment of
1- Pediatric Congestive Heart Failure, and
2- Huntington's Disease
Tishcon Corp. was also granted an Orphan Drug Designation for Coenzyme Q10
(Ubi-Q-Gel(R)) in the treatment of Mitochondrial Cytopathies, in 1999.
Posted by Dave at April 19, 2004 08:40 PM
Trackback Pings
TrackBack URL for this entry:
http://www.huntingtons.info/MT/mt-tb.cgi/409
Comments
Post a comment
Thanks for signing in, . Now you can comment. (sign out)
(If you haven't left a comment here before, you may need to be approved by the site owner before your comment will appear. Until then, it won't appear on the entry. Thanks for waiting.)